Credit Suisse raised the price target for the CME Group Inc. (NASDAQ:CME) stock from “a Neutral” to “an Outperform”. The rating was released on January 05, 2023, according to finviz. We previously noted in another research note published on October 12, 2022 by Deutsche Bank that upgraded the stock from a Hold to a Buy with a price target of $200 for CME stock. The research report from Citigroup has initiated the stock to Buy, with a price target set at $220. The stock was initiated by Rosenblatt, who disclosed in a research note on August 17, 2022, to Sell and set the price objective to $171.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of CME Group Inc. (NASDAQ:CME) dipped -0.71% to close Tuesday’s market session at $173.13, lower as compared to yesterday’s close. The stock price fluctuated between $171.93 and $175.99 throughout the trading session with the volume trading being 1550407 shares, which represented a significant variation when compared to the three months average volume of 2.11 million shares. The firm’s stock price fluctuated -1.63% within the last five trades and 2.82% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -13.07% in the last 6 months and 4.56% was added to its value over the previous 3 months. CME stock is trading at a margin of 0.33%, 1.05% and -7.78% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, CME deals in the Financial domain. The stock is trading -30.82 percent below its 52-week high and 6.70 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -23.2. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does CME Group Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 61.20 percent and the profit margin is 53.10 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $62.00 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for CME Group Inc. (NASDAQ:CME) is 23.62. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 20.91. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 12.50 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 2.20, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.20 percent of CME Group Inc. shares are owned by insiders, and 88.20 percent are held by financial institutions. SHEPARD WILLIAM R, the Director at CME Group Inc. (CME) has bought 1,244 shares of firm on Jan 18 at a price of $175.98 against the total amount of $0.22 million. In another inside trade, SHEPARD WILLIAM R, Director of CME Group Inc. (NASDAQ:CME) bought 55 shares of the firm on Jan 18 for a total worth of $9651.0 at a price of $175.98. An inside trade which took place on Dec 28, Director of CME Group Inc. SHEPARD WILLIAM R bought 289 shares of firm against total price of $48645.0 at the cost of $168.11 per share.